Article
MiR-23a Functions as a Tumor Suppressor in Osteosarcoma
1 Jan 2014
Abstract excerpt
BACKGROUND: Osteosarcoma is the most common primary bone malignancy in children and adolescents, and the pathogenesis of this cancer remains unclear. Therefore, the discovery of new biomarkers for the diagnosis, prognosis, and treatment of osteosarcoma remains an important but unmet clinical need. METHOD: Quantitative real-time PCR was carried out to examine the expression of miR-23a. Methylation-specific PCR was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
